Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

HKG:1066 Revenue

Shandong Weigao Group Medical Polymer Company had revenue of 6.85B CNY in the half year ending June 30, 2026, with 3.21% growth. This brings the company's total for the last twelve months to 13.59B, up 3.81% year-over-year. In the year 2025, Shandong Weigao Group Medical Polymer Company had annual revenue of 13.39B with 2.31% growth. That makes Shandong Weigao Group Medical Polymer Company the 4,953rd largest company in the world by revenue and 331st in Hong Kong.

• Revenue (ttm): 13.59B CNY
• Revenue Growth: +3.81%
• P/S Ratio: 0.93
• Revenue / Employee: 1.02M CNY
• Employees: 13,310
• Market Cap: 14.52B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Segment

By Segment

Chart

• Medical Device Products 6.67B 49.5%
• Pharma Packaging Products 2.29B 17.0%
• Interventional Products 2.01B 14.9%
• Orthopaedic Products 1.52B 11.3%
• Blood Management Products 995.11M 7.4%

By Geography

Chart

• People's Republic of China (PRC) 9.82B 73.3%
• United States 1.45B 10.8%
• Other 1.14B 8.5%
• Europe, The Middle East and Africa 983.23M 7.3%

Fiscal year ended Dec 31, 2025 See the full HKG:1066 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	13.39B	301.82M	2.31%
Dec 31, 2024	13.09B	-142.38M	-1.08%
Dec 31, 2023	13.23B	-518.02M	-3.77%
Dec 31, 2022	13.75B	538.53M	4.08%
Dec 31, 2021	13.21B	1.59B	13.65%

Data Source: S&P Global Market Intelligence Last updated: Sep 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 20, 2026

Data Sources Report a data error